Telo Genomics Corp's total assets for Q1 2026 were C$606.90K, a decrease of -33.40% from the previous quarter. TSE:TELO total liabilities were C$633.60K for the fiscal quarter, a 59.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.